Preliminary Program subject to change
Medicinal Chemistry
Presentation TypeOral
Summary Statement
Presider:Joel S. Freundlich, Jacobus Pharmaceutical Company, Princeton, NJ
Epoxybergamottin as a bioactive compound for functional foods applications
Samineh Madani and Jack N. Losso, Louisiana State University, Baton Rouge, LA
Synthesis of small molecules designed to complement disease-associated thyroid hormone receptor mutants
A. Quamrul Hassan and John T. Koh, University of Delaware, Newark, DE
Potent, low-calcemic, selective inhibitors of CYP24 hydroxylase: 24-sulfone analogs of the hormone 1a,25-dihydroxyvitamin D3
Gary H. Posner, Kenneth R. Crawford, Hong Woon Yang, Mehmet Kahraman, Heung Bae Jeon, Hongbin Li, Jae Kyoo Lee, Byung Chul Suh, Mark A. Hatcher, Tanzina Mirza, Aimee Usera, Patrick M. Dolan and Thomas W. Kensler, The Johns Hopkins University, Baltimore, MD
Exploration of the Potential Antifilarial Activity of the Fruit, Leaf and Stem Extracts of Melia azedarach Linn. on Cattle Filarial Parasite Setaria Cervi
Qamar U. Ahmed1, S. M. K. R. Zaidi2, N.U. Khan2 and K.C. Singhal2, (1)International Islamic University Malaysia, Kuantan-25200, PahangDM, Malaysia, (2)Aligarh Muslim University, Aligarh-UP, India
Potent, Selective and Low-Calcemic Inhibitors of CYP 24 Hydroxylase: 24-Sulfoximine Analogues of the Hormone 1α,25-Dihydroxyvitamin D3
Mehmet Kahraman1, Sandra Sinishtaj1, Patrick M. Dolan1, Thomas W. Kensler1, Sara Peleg2 and Gary H. Posner1, (1)The Johns Hopkins University, Baltimore, MD, (2)The University of Texas
Structure-based Design of a Barbiturate Containing Inhibitor of MMP-13
William Pitts, Soong-Hoon Kim, Andrew Pudzianowski, Kenneth J. Leavitt, Joseph Barbosa, Patricia A. McDonnell, Bruce M. Rankin, Richard Liu, Wayne Vacarro, William Metzler, Steven Sherriff and Bruce Jacobson, Bristol-Myers Squibb, Princeton, NJ

General Submissions